Neuphoria Therapeutics Inc（NEUP）價格預測NEUPNeuphoria Therapeutics Inc

Alphio's NEUP stock price prediction model matches the current Neuphoria Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.88 (+3.61%). The 1-week path is $2.90 (+4.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Neuphoria Therapeutics Inc. is not a good buy right now due to its declining financial performance and negative market sentiment. The stock has dropped 43.27% over the past year and currently has an RSI of 9.449, indicating it is oversold but also reflects a lack of buying interest. The forward P/E ratio is 0, suggesting uncertainty in future earnings, and recent news about Merck halting a key drug trial has negatively impacted investor confidence, leading to a 19% drop in NEUP's stock price. The main risk is the significant 8.85% decline in the stock over the last 5 days, which indicates continued downward momentum.

Neuphoria Therapeutics Inc (NEUP) last closed at $2.78, gaining +0.36%. These facts feed the 1-day and 1-week NEUP price prediction above.